Croda International - Britains Most Admired Company for Innovation
Yorkshire-based Croda International, manufacturers of speciality chemical ingredients that enhance everyday consumer and industrial products, has just been awarded first place in the innovation segment, second in the chemical sector category and eighth place overall in the 2014 Britain’s Most Admired Companies Awards.
The Management Today awards are the largest awards of their kind in the UK; they highlight corporate reputation by recognising key factors critical to business success, with winners identified by means of peer review.
Steve Foots, Chief Executive of Croda said: “To be named Britain’s most Innovative Company is a fantastic accolade and we are hugely proud to collect this award. Innovation runs through every part of our business and for this to be recognised by industry peers, and the investment community, is testament to the dedication and hard work of our employees across the globe.”
Organisations are scored against nine performance areas; from quality of management, financial soundness and quality of goods and services, to the ability to attract, develop and retain top talent, the capacity to innovate and commitment to community and environmental responsibility. Opinions on these areas are sought from more than 200 Board members at some of the UK’s largest companies, as well as analysts and City commentators.
Commenting on the results, Matthew Gywther, editor of Management Today said; “Croda took the 2014 criteria award for Capacity to Innovate, in recognition of its world-class reputation for generating new ideas for its customers and bringing them to market.
“Researched by Prof Mike Brown and his team at Birmingham City University, and with a history dating back over 20 years, Britain's Most Admired Companies provides a fascinating insight into that most hard-won of intangible assets, corporate reputation.”
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance